Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析

◆英語タイトル:Laboratorios Farmaceuticos Rovi SA (ROVI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14903
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products comprise imaging contrast media and contrast injection systems. Rovi’s prescription products are used in the treatment of diseases such as osteoporosis, chronic obstructive pulmonary disease, degenerative osteoarthritis, coronary artery disease and chronic heart failure, among others. The company has operations in Italy, the UK, Austria, Ireland, Hungary, Poland, Spain, Portugal and others. Rovi is headquartered in Madrid, Spain.

Laboratorios Farmaceuticos Rovi SA Key Recent Developments

Sep 22,2018: ROVI announces an agreement with Biogaran for the marketing of its enoxaparin biosimilar in France
Jul 26,2018: ROVI: First half 2018 results
Apr 25,2018: Rovi Reports Operating Revenue Growth of 12% Underpinned by Outstanding Bemiparin Sales

This comprehensive SWOT profile of Laboratorios Farmaceuticos Rovi SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Laboratorios Farmaceuticos Rovi SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Laboratorios Farmaceuticos Rovi SA – Key Information
Laboratorios Farmaceuticos Rovi SA – Overview
Laboratorios Farmaceuticos Rovi SA – Key Employees
Laboratorios Farmaceuticos Rovi SA – Key Employee Biographies
Laboratorios Farmaceuticos Rovi SA – Key Operational Heads
Laboratorios Farmaceuticos Rovi SA – Major Products and Services
Laboratorios Farmaceuticos Rovi SA – History
Laboratorios Farmaceuticos Rovi SA – Company Statement
Laboratorios Farmaceuticos Rovi SA – Locations And Subsidiaries
Laboratorios Farmaceuticos Rovi SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Laboratorios Farmaceuticos Rovi SA – Business Description
Laboratorios Farmaceuticos Rovi SA – Corporate Strategy
Laboratorios Farmaceuticos Rovi SA – SWOT Analysis
SWOT Analysis – Overview
Laboratorios Farmaceuticos Rovi SA – Strengths
Laboratorios Farmaceuticos Rovi SA – Weaknesses
Laboratorios Farmaceuticos Rovi SA – Opportunities
Laboratorios Farmaceuticos Rovi SA – Threats
Laboratorios Farmaceuticos Rovi SA – Key Competitors

Section 3 – Company Financial Performance Charts

Laboratorios Farmaceuticos Rovi SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Laboratorios Farmaceuticos Rovi SA, Key Information
Laboratorios Farmaceuticos Rovi SA, Key Ratios
Laboratorios Farmaceuticos Rovi SA, Share Data
Laboratorios Farmaceuticos Rovi SA, Major Products and Services
Laboratorios Farmaceuticos Rovi SA, History
Laboratorios Farmaceuticos Rovi SA, Key Employees
Laboratorios Farmaceuticos Rovi SA, Key Employee Biographies
Laboratorios Farmaceuticos Rovi SA, Key Operational Heads
Laboratorios Farmaceuticos Rovi SA, Other Locations
Laboratorios Farmaceuticos Rovi SA, Subsidiaries
Laboratorios Farmaceuticos Rovi SA, Key Manufacturing facilities
Laboratorios Farmaceuticos Rovi SA, Key Competitors
Laboratorios Farmaceuticos Rovi SA, SWOT Analysis
Laboratorios Farmaceuticos Rovi SA, Ratios based on current share price
Laboratorios Farmaceuticos Rovi SA, Annual Ratios
Laboratorios Farmaceuticos Rovi SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Laboratorios Farmaceuticos Rovi SA, Performance Chart
Laboratorios Farmaceuticos Rovi SA, Ratio Charts

★海外企業調査レポート[Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Avarga Ltd:企業の戦略・SWOT・財務情報
    Avarga Ltd - Strategy, SWOT and Corporate Finance Report Summary Avarga Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kenya Electricity Generating Co Ltd (KGEN):企業の財務・戦略的SWOT分析
    Kenya Electricity Generating Co Ltd (KGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Tung Lok Restaurants (2000) Ltd.:企業の戦略・SWOT・財務情報
    Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products such as tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease; consti …
  • ECA S.A.:企業の戦略・SWOT・財務情報
    ECA S.A. - Strategy, SWOT and Corporate Finance Report Summary ECA S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Asahi Kasei Corp (3407):企業の財務・戦略的SWOT分析
    Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Wesco Aircraft Holdings Inc:企業の戦略・SWOT・財務分析
    Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Penumbra Inc (PEN):企業の財務・戦略的SWOT分析
    Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ansaldo STS SpA:企業の戦略・SWOT・財務情報
    Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report Summary Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BerGenBio ASA (BGBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Rosneft Oil Co (ROSN):電力:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務情報
    OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report Summary OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SNCF Mobilites Group:企業の戦略・SWOT・財務情報
    SNCF Mobilites Group - Strategy, SWOT and Corporate Finance Report Summary SNCF Mobilites Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Sulzer Ltd (SUN):企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆